Immune-Related Adverse Events after Immune Check Point Inhibitors: Understanding the Intersection with Autoimmunity

Scientists address the question of whether the mechanisms that drive immune checkpoint inihibitor (ICI)-induced immune-related adverse events are shared or distinct with those driving spontaneous autoimmunity, focusing on ICI-induced diabetes, ICI-induced arthritis, and ICI-induced thyroiditis.